-
1دورية أكاديميةPerspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy).
المؤلفون: Ascierto, Paolo A., Agarwala, Sanjiv S., Blank, Christian, Caracò, Corrado, Carvajal, Richard D., Ernstoff, Marc S., Ferrone, Soldano, Fox, Bernard A., Gajewski, Thomas F., Garbe, Claus, Grob, Jean-Jacques, Hamid, Omid, Krogsgaard, Michelle, Lo, Roger S., Lund, Amanda W., Madonna, Gabriele, Michielin, Olivier, Neyns, Bart, Osman, Iman, Peters, Solange
المصدر: Journal of Translational Medicine; 9/4/2022, Vol. 20 Issue 1, p1-21, 21p
مصطلحات موضوعية: IPILIMUMAB, PEMBROLIZUMAB, PATIENT selection, IMMUNE checkpoint inhibitors, MEDICAL research, MELANOMA, IMMUNE checkpoint proteins
مصطلحات جغرافية: NAPLES (Italy), ITALY
-
2دورية أكاديمية
المؤلفون: Gulati, Nicholas, Celen, Arda, Johannet, Paul, Mehnert, Janice M., Weber, Jeffrey, Krogsgaard, Michelle, Osman, Iman, Zhong, Judy
المصدر: Cancer Medicine; Nov2021, Vol. 10 Issue 21, p7457-7465, 9p
مصطلحات موضوعية: IMMUNE checkpoint inhibitors, GENDER differences (Sociology), MELANOMA, CLINICAL trials monitoring, DRUG side effects, IPILIMUMAB, NLRP3 protein
-
3دورية أكاديمية
المصدر: Oncology; 2020, Vol. 98 Issue 12, p847-852, 6p
مصطلحات موضوعية: THERAPEUTIC use of antineoplastic agents, ACADEMIC medical centers, CANCER patients, CANCER relapse, LONGITUDINAL method, MEDICAL records, MELANOMA, PREGNANCY complications, TUMOR classification, DECISION making in clinical medicine, RETROSPECTIVE studies, IPILIMUMAB, INDOLE compounds, ACQUISITION of data methodology, PREGNANCY
مصطلحات جغرافية: NEW York (State)
-
4دورية أكاديمية
المؤلفون: Donnelly, Douglas, Bajaj, Shirin, Jaehong Yu, Hsu, Miles, Balar, Arjun, Pavlick, Anna, Weber, Jeffrey, Osman, Iman, Judy Zhong
المصدر: Journal for ImmunoTherapy of Cancer; 12/1/2019, Vol. 7 Issue 1, p1-8, 8p
مصطلحات موضوعية: IPILIMUMAB, IMMUNE checkpoint inhibitors, BODY mass index, OBESITY paradox, IMMUNE response, OVERALL survival
-
5دورية أكاديمية
المؤلفون: Ferguson, Robert1,2,3 (AUTHOR), Chat, Vylyny1,2,3 (AUTHOR), Morales, Leah1,2,3 (AUTHOR), Simpson, Danny1,2,3 (AUTHOR), Monson, Kelsey R.1,2,3 (AUTHOR), Cohen, Elisheva1,2,3 (AUTHOR), Zusin, Sarah1,2,3 (AUTHOR), Madonna, Gabriele4 (AUTHOR), Capone, Mariaelena4 (AUTHOR), Simeone, Ester4 (AUTHOR), Pavlick, Anna5 (AUTHOR), Luke, Jason J.6,7 (AUTHOR), Gajewski, Thomas F.8,9,10 (AUTHOR), Osman, Iman1,3,11,12 (AUTHOR), Ascierto, Paolo4 (AUTHOR), Weber, Jeffrey1,3,11 (AUTHOR), Kirchhoff, Tomas1,2,3 (AUTHOR) Tomas.Kirchhoff@nyulangone.org
المصدر: European Journal of Cancer. Aug2023, Vol. 189, pN.PAG-N.PAG. 1p.
مصطلحات موضوعية: *DRUG efficacy, *IMMUNE checkpoint inhibitors, *B cells, *CONFIDENCE intervals, *MELANOMA, *IPILIMUMAB, *IMMUNOMODULATORS, *GENETIC variation, *ALLELES, *GENE expression, *RISK assessment, *GENOTYPES, *DESCRIPTIVE statistics, *DRUG side effects, *TUMOR markers, *ODDS ratio, *LONGITUDINAL method, *DRUG toxicity